NAD+ (Nicotinamide adenine dinucleotide) for Injection recall
FDA recall D-0094-2026 · initiated Jul 30, 2025
GenoGenix LLC recalled NAD+ (Nicotinamide adenine dinucleotide) for Injection in Jul 2025 — an FDA Class I recall (D-0094-2026) because Microbial Contamination of Sterile Products: elevated endotoxin levels.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Microbial Contamination of Sterile Products: elevated endotoxin levels
Sterility could not be assured
The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Details
- Product
- NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.
- Recalling company
- GenoGenix LLC
- Classification
- Class I
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- US Nationwide.
- Initiated
- Jul 30, 2025
- FDA report date
- Oct 15, 2025
Frequently asked
- Was NAD+ (Nicotinamide adenine dinucleotide) for Injection recalled?
- GenoGenix LLC recalled NAD+ (Nicotinamide adenine dinucleotide) for Injection in Jul 2025 — an FDA Class I recall (D-0094-2026) because Microbial Contamination of Sterile Products: elevated endotoxin levels. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was NAD+ (Nicotinamide adenine dinucleotide) for Injection recalled?
- Per the FDA enforcement record, the reason for recall D-0094-2026 was: Microbial Contamination of Sterile Products: elevated endotoxin levels
- Is a recalled NAD+ (Nicotinamide adenine dinucleotide) for Injection dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of NAD+ (Nicotinamide adenine dinucleotide) for Injection are affected?
- Distributed: US Nationwide.. The recall covers these lots — Lot#: GG121624-023, within expiry. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0094-2026.